Introducing NasalOxy®: Revolutionizing Oxygen Therapy for Comfort and Efficiency

CNSAC MedShop is thrilled to introduce NasalOxy®, a groundbreaking advancement in oxygen therapy. This innovative, patented low-flow nasal cannula addresses common issues with traditional oxygen delivery methods, providing unmatched comfort and effectiveness for patients needing long-term oxygen therapy.

The Problem with Traditional Oxygen Therapy

Long-term oxygen therapy (LTOT) is crucial for managing chronic respiratory conditions such as COPD, cystic fibrosis, asthma, pneumonia, congestive heart failure, and sleep apnea. COPD alone affects over 16 million Americans and is the third leading cause of death in the U.S. Conditions like sleep apnea impact over 18 million Americans, and asthma affects more than 300 million people worldwide. The demand for effective low-flow oxygen delivery is clear. However, traditional methods like face masks and standard nasal cannulas often fall short in both comfort and efficacy.

Traditional methods, such as face masks and standard nasal cannulas, often fail to provide adequate comfort and effectiveness, leading to various issues including nasal dryness, discomfort, irritation, and potential complications. Research shows that intranasal humidity drops significantly from 40.3% to 29.0% at an oxygen flow rate of 3 liters per minute when using a standard nasal cannula without humidification.

Face masks, while effective in oxygen delivery, often pose challenges such as discomfort, skin irritation, difficulty in eating or speaking, and occasional infection and bleeding. Studies indicate that up to 30% of patients experience significant discomfort and skin irritation with traditional face masks, leading to reduced compliance and therapy effectiveness.

Standard nasal cannulas, while less cumbersome, frequently fail to deliver adequate oxygen for both nasal and oral breathing, affecting up to 50% of patients due to nasal dryness and irritation.

Chronic exposure to dry oxygen can lead to mucosal dryness, irritation, inflammation, bleeding, and potentially nasal septal perforation. Additionally, the tubing and positioning of traditional nasal cannulas can cause discomfort, especially during prolonged use or while sleeping.

In addressing these challenges, a new generation of oxygen delivery devices, such as NasalOxy®, aims to provide enhanced comfort, effectiveness, and safety for patients requiring LTOT.

 The NasalOxy® Solution

NasalOxy® is designed to overcome these challenges, offering a state-of-the-art solution that combines comfort and effectiveness. Its unique design prevents airway inflammation and ensures consistent oxygen delivery.

Key Features of NasalOxy®:

1. Dual Breathing Support: Supports both nasal and oral breathing, making it versatile for various patient needs.

2. Comfortable Design: Advanced design reduces contact with the mucous membrane, preventing irritation and discomfort and other side effects associated with traditional nasal cannulas.

3. Optimal Oxygen Delivery: Ensures sufficient and consistent oxygen supply, maintaining proper oxygenation levels without higher flow rates.

4. User-Friendly: Lightweight and unobtrusive, allowing patients to eat, talk, and sleep comfortably without experiencing a reduction in PaO2 levels.

5.Versatile Application: Suitable for both home and clinical oxygen therapy, NasalOxy® offers flexibility in addressing the needs of patients across various settings, ensuring seamless integration into their daily lives.

Proven Clinical Benefits

Clinical studies have shown that NasalOxy® significantly improves oxygenation compared to traditional face masks. In tests with both healthy subjects and patients with COPD, NasalOxy® increased oxygen flow by an average of 2 L/min, reducing hypercapnia and respiratory discomfort. Its enlarged outlet area and turbulence control decelerate the oxygen flow, mimicking natural breathing and making oxygen delivery feel natural and non-intrusive.

Real-World Applications

NasalOxy® is ideal for both home oxygen therapy and clinical settings. It is especially beneficial for patients with conditions requiring consistent and reliable oxygen delivery, such as COPD, cystic fibrosis, and severe asthma. Its ease of use and patient-friendly design improve compliance with LTOT, leading to better health outcomes.

Patient Feedback

Patients who have switched to NasalOxy® from traditional face masks and nasal cannulas report significant improvements in their quality of life. They highlight the comfort and ease of use, noting they can perform daily activities without constant irritation.

Conclusion

At CNSAC, our mission is to enhance the quality of life for individuals needing long-term oxygen therapy. NasalOxy® exemplifies our commitment to innovation and patient care. With its cutting-edge design and proven efficacy, NasalOxy® is poised to transform oxygen therapy, offering a more comfortable and effective solution for patients globally.

– For more information about NasalOxy® and to place an order, please visit our website at https://www.cnsac-medshop.com/innovative-and-patented-low-flow-nasal-cannula-for-both-mouth-and-nose-breathing/

– For U.S. orders, contact us at [usa@cnsac.com] or call +1 856-682 4128.

– Experience the future of oxygen therapy with NasalOxy® today!